ethylurea has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benoit-Biancamano, MO; C-Gaudreault, R; Fortin, JS | 1 |
1 other study(ies) available for ethylurea and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Discovery of ethyl urea derivatives as inhibitors of islet amyloid polypeptide fibrillization and cytotoxicity.
Topics: Amyloid; Amyloidosis; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Islets of Langerhans; Small Molecule Libraries; Urea | 2016 |